Mechanistic basis of a combination d-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo
Authors:
- 1 May 2015
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 95 (1) , 28-37
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
- Ministry of Science and Technology, Taiwan (103-2325-B-400-012)
- National Health Research Institutes (CA-103-PP-22)
- National Research Program for Biopharmaceuticals
- National Cheng Kung University (D103-35A09)
- Ministry of Health and Welfare (CA103-SP-01)
This publication has 31 references indexed in Scilit:
- Overcoming Platinum Resistance through the Use of a Copper-Lowering AgentMolecular Cancer Therapeutics, 2012
- Comparative epidemiology of gastric cancer between Japan and ChinaWorld Journal of Gastroenterology, 2011
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer DrugsMolecular Pharmacology, 2010
- Transcription Factor Sp1 Plays an Important Role in the Regulation of Copper Homeostasis in Mammalian CellsMolecular Pharmacology, 2008
- Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracilBritish Journal of Cancer, 2007
- The roles of copper transporters in cisplatin resistanceCancer and Metastasis Reviews, 2007
- Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugsCritical Reviews in Oncology/Hematology, 2005
- Palliative chemotherapy for advanced gastric cancerAnnals of Oncology, 2004
- The Copper Export Pump ATP7B Modulates the Cellular Pharmacology of Carboplatin in Ovarian Carcinoma CellsMolecular Pharmacology, 2003
- Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panelBiochemical Pharmacology, 1996